Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
COVID-19 underscores historical precedent for fear-driven responses that disregard autonomy among persons with low income who are also persons of color.
AMA J Ethics. 2021;23(11):E840-846. doi:
10.1001/amajethics.2021.840.
Gregory C. Gray, MD, MPH, Laura A. Pulscher, PhD, MSc, and Hisham O. Alsharif, MBBS
Since the 1990s, multiple infectious diseases have “spilled over” from nonhuman animals to infect humans and cause significant global morbidity and mortality.
AMA J Ethics. 2024;26(2):E122-131. doi:
10.1001/amajethics.2024.122.
Antimicrobial resistance demonstrates the fruitfulness of public health and bioethics collaborations by applying key concepts of interconnection and interdependence.
AMA J Ethics. 2024;26(2):E162-170. doi:
10.1001/amajethics.2024.162.
Dr Joost van Herten joins Ethics Talk to discuss how comparing different conceptions of health can help us interrogate just exactly what a One Health approach to health offers and what it doesn't.
Amy B. Cadwallader, PhD, Kavitha Nallathambi, MPH, MBA, and Carly Ching, PhD
Poor-quality antimicrobial medicines continue to proliferate across supply chains, threatening patients’ health and safety, especially in low- and middle-income regions.
AMA J Ethics. 2024;26(6):E472-478. doi:
10.1001/amajethics.2024.472.